Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

Citation
B. Bussolati et al., Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide, AM J PATH, 159(3), 2001, pp. 993-1008
Citations number
45
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
159
Issue
3
Year of publication
2001
Pages
993 - 1008
Database
ISI
SICI code
0002-9440(200109)159:3<993:VEGFRM>2.0.ZU;2-Q
Abstract
The known responses of vascular endothelial growth factor (VEGF) are mediat ed through VEGF receptor-2 (VEGFR-2/KDR) in endothelial cells. However, it is unknown whether VEGFR-1 (Flt-1) is an inert decoy or a signaling recepto r for VEGF during physiological or pathological angiogenesis. Here we repor t that VEGF-stimulated nitric oxide (NO) release is inhibited by blockade o f VEGFR-1 and that VEGFR-1 via NO negatively regulates of VEGFR-2-mediated proliferation and promotes formation of capillary networks in human umbilic al vein endothelial cells (HUVECs). Inhibition of VEGFR-1 in a murine Matri gel angiogenesis assay induced large aneurysm-like structures. VEGF-induced capillary growth over 14 days was inhibited by anti-VEGFR-2-blocking antib ody as determined by reduced tube length between capillary connections (P < 0.0001) in an in vitro angiogenesis assay. In contrast, loss of VEGFR-1 ac tivity with a neutralizing anti-VEGFR-1 antibody resulted in an increase in the accumulation of endothelial cells (P < 0.0001) and a dramatic decrease in the number of capillary connections that were restored by the addition of No donor. Porcine aortic endothelial (PAE) cells expressing human VEGFR- 1 but not VEGFR-2 plated on growth factor-reduced Matrigel rearranged into tube-like structures that were prevented by anti-VEGFR-1 antibody or a cGMP inhibitor. VEGF stimulated NO release from VEGFR-1- but not VEGFR-2-transf ected endothelial cells and placenta growth factor-1 stimulated NO release in HUVECs. Blockade of VEGFR-1 increased VEGF-mediated HUVEC proliferation that was inhibited by NO donors, and potentiated by NO synthase inhibitors. These data indicate that VEGFR-1 is a signaling receptor that promotes end othelial cell differentiation into vascular tubes, in part by limiting VEGF R-2-mediated endothelial cell proliferation via NO, which seems to be a mol ecular switch for endothelial cell differentiation.